SynthesisClinical journal of gastroenterology2025

Evaluation of fruquintinib's efficacy and safety in refractory metastatic colorectal cancer: a systematic review and meta-analysis of phase II and III randomized controlled trials.

Eric Ricardo Yonatan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.